Published in Oncogene on March 01, 1992
Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A (1995) 3.28
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol (1995) 2.93
Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. EMBO J (1999) 1.76
The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation. Nucleic Acids Res (1996) 1.33
Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter. J Virol (1996) 1.24
An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter. Nucleic Acids Res (1994) 1.05
Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases. Mol Biol Cell (2001) 1.03
Induction of gene expression by exon 2 of the major E1A proteins of adenovirus type 5. J Virol (1993) 0.97
Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors. J Virol (2010) 0.97
The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation. EMBO J (1992) 0.97
Axl-gas6 interaction counteracts E1A-mediated cell growth suppression and proapoptotic activity. Mol Cell Biol (1999) 0.92
Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection. Proc Natl Acad Sci U S A (1996) 0.91
Repression of RNA polymerase III transcription by adenovirus E1A. J Virol (1993) 0.85
AR1 is an integral part of the adenovirus type 2 E1A-CR3 transactivation domain. J Virol (1998) 0.83
Suppression of E1A-mediated transformation by the p50E4F transcription factor. Mol Cell Biol (1999) 0.77
Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses. Nature (1979) 6.60
The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA. Cell (1980) 5.80
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol (1997) 4.69
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol (1996) 4.00
A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet (1998) 3.65
Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2. Proc Natl Acad Sci U S A (1980) 3.45
Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature (1996) 3.12
Adenovirus 2 early region 1A stimulates expression of both viral and cellular genes. EMBO J (1984) 3.03
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol (1995) 2.93
Crystal structure of the NG domain from the signal-recognition particle receptor FtsY. Nature (1997) 2.51
Susceptibility locus for Alzheimer's disease on chromosome 10. Science (2000) 2.49
Controls of RNA splicing and termination in the major late adenovirus transcription unit. Nature (1981) 2.49
Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature (1998) 2.26
Multiple spatially specific enhancers are required to reconstruct the pattern of Hox-2.6 gene expression. Genes Dev (1991) 2.20
Adenovirus VA RNAI: a positive regulator of mRNA translation. Mol Cell Biol (1984) 2.09
Adenovirus early gene products may control viral mRNA accumulation and translation in vivo. Cell (1981) 1.93
Role of a conserved retinoic acid response element in rhombomere restriction of Hoxb-1. Science (1994) 1.91
Splicing of adenovirus 2 early region 1A mRNAs is non-sequential. J Mol Biol (1983) 1.82
Adenovirus VA RNAI mediates a translational stimulation which is not restricted to the viral mRNAs. EMBO J (1985) 1.80
Sequence analysis of adenovirus DNA: complete nucleotide sequence of the spliced 5' noncoding region of adenovirus 2 hexon messenger RNA. Cell (1979) 1.73
The zinc finger gene Krox20 regulates HoxB2 (Hox2.8) during hindbrain segmentation. Cell (1993) 1.70
Segmental expression of Hoxb2 in r4 requires two separate sites that integrate cooperative interactions between Prep1, Pbx and Hox proteins. Development (2000) 1.69
An automated flinch detecting system for use in the formalin nociceptive bioassay. J Appl Physiol (1985) (2001) 1.68
Sequence analysis of adenovirus DNA. I. Nucleotide sequence at the carboxy-terminal end of the gene for adenovirus type 2 hexon. Virology (1978) 1.66
The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J (1999) 1.63
Sensitive periods for glucocorticoids' regulation of Na+,K(+)-ATPase mRNA in the developing lung and kidney. Pediatr Res (1993) 1.62
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J (2001) 1.61
Genetic identification of an endoproteinase encoded by the adenovirus genome. J Mol Biol (1983) 1.58
Sequence analysis of adenovirus DNA. IV. The genomic sequences encoding the common tripartite leader of late adenovirus messenger RNA. J Mol Biol (1979) 1.55
The carboxy-terminal region of adenovirus E1A activates transcription through targeting of a C-terminal binding protein-histone deacetylase complex. FEBS Lett (1998) 1.55
Genetic interactions between Hoxa1 and Hoxb1 reveal new roles in regulation of early hindbrain patterning. Development (1998) 1.54
Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs. Mol Cell Biol (1994) 1.54
A mechanism by which adenovirus virus-associated RNAI controls translation in a transient expression assay. Mol Cell Biol (1987) 1.53
Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy (1991) 1.52
Environmental tobacco smoke and lung cancer in nonsmokers: does time since exposure play a role? Epidemiology (1998) 1.51
Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology (Oxford) (2002) 1.51
Sequences involved in the control of adenovirus L1 alternative RNA splicing. Nucleic Acids Res (1991) 1.51
Gene and mRNA for precursor polypeptide VI from adenovirus type 2. J Virol (1981) 1.49
Adenovirus 3 fiber polypeptide gene: implications for the structure of the fiber protein. J Virol (1985) 1.47
A novel adenovirus-2 E1A mRNA encoding a protein with transcription activation properties. EMBO J (1987) 1.47
Nucleotide sequence at the junction between the coding region of the adenovirus 2 hexon messenger RNA and its leader sequence. Proc Natl Acad Sci U S A (1978) 1.45
DNA sequence analysis of the region encoding the terminal protein and the hypothetical N-gene product of adenovirus type 2. J Biol Chem (1982) 1.44
Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model. Ann Allergy Asthma Immunol (2000) 1.42
The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci (2001) 1.41
Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells. J Gen Virol (1987) 1.40
Region E3 of human adenoviruses; differences between the oncogenic adenovirus-3 and the non-oncogenic adenovirus-2. Gene (1986) 1.39
The adenovirus E4-ORF4 splicing enhancer protein interacts with a subset of phosphorylated SR proteins. EMBO J (2001) 1.36
Segmental expression of Hoxa-2 in the hindbrain is directly regulated by Krox-20. Development (1996) 1.35
Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group. Ann Oncol (1996) 1.33
The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation. Nucleic Acids Res (1996) 1.33
Two adenovirus proteins with redundant activities in virus growth facilitates tripartite leader mRNA accumulation. Virology (1993) 1.33
The sequence of the 3' non-coding region of the hexon mRNA discloses a novel adenovirus gene. Nucleic Acids Res (1981) 1.31
Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma. J Biol Chem (1998) 1.30
Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A. Cell Growth Differ (2000) 1.29
Residential radon exposure and lung cancer in Swedish women. Health Phys (1992) 1.27
Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys (1999) 1.25
Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter. J Virol (1996) 1.24
Neuroblastoma. Effect of genetic factors on prognosis and treatment. Cancer (1992) 1.23
Defective RNA splicing in the absence of adenovirus-associated RNAI. Proc Natl Acad Sci U S A (1986) 1.23
The use of the nose to study the inflammatory response of the respiratory tract. Thorax (1992) 1.22
Polyadenylic acid addition sites in the adenovirus type 2 major late transcription unit. J Virol (1983) 1.22
Beta cell proliferation and growth factors. J Mol Med (Berl) (1999) 1.20
Splicing of the adenovirus-2 E1A 13S mRNA requires a minimal intron length and specific intron signals. Nucleic Acids Res (1985) 1.19
A novel effect of adenovirus VA RNA1 on cytoplasmic mRNA abundance. Virology (1990) 1.17
Background factors in patients with schizoaffective disorder as compared with patients with diabetes and healthy individuals. Eur Arch Psychiatry Clin Neurosci (1996) 1.16
The gene for the adenovirus 2 hexon polypeptide. J Biol Chem (1984) 1.15
A U1 snRNA binding site improves the efficiency of in vitro pre-mRNA splicing. Nucleic Acids Res (1991) 1.13
Crystal structure of phosphoadenylyl sulphate (PAPS) reductase: a new family of adenine nucleotide alpha hydrolases. Structure (1997) 1.13
MRI of the lung (1/3): methods. Insights Imaging (2012) 1.12
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. Eur J Cancer (2008) 1.12
'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group. Eur J Cancer (1995) 1.12
Randomized trial of Lichtenstein versus Shouldice hernia repair in general surgical practice. Br J Surg (2002) 1.11
Neurogenin 3+ cells contribute to β-cell neogenesis and proliferation in injured adult mouse pancreas. Cell Death Dis (2013) 1.11
Arctic terrestrial ecosystem contamination. Sci Total Environ (1992) 1.11
Independent regulation of initiation and maintenance phases of Hoxa3 expression in the vertebrate hindbrain involve auto- and cross-regulatory mechanisms. Development (2001) 1.09
The social network of patients with schizoaffective disorder as compared to healthy individuals. Soc Sci Med (1995) 1.09
Control of adenovirus major late gene expression at multiple levels. J Mol Biol (1992) 1.08
Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet (2001) 1.08
Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner. Mol Cell Biol (2001) 1.07
The adenovirus hexon protein. The primary structure of the polypeptide and its correlation with the hexon gene. J Biol Chem (1981) 1.07
Role of the branch site/3'-splice site region in adenovirus-2 E1A pre-mRNA alternative splicing: evidence for 5'- and 3'-splice site co-operation. Nucleic Acids Res (1989) 1.06
Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA. Thorax (1993) 1.05
An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter. Nucleic Acids Res (1994) 1.05
Measles outbreaks on the horizon? Trends Immunol (2001) 1.04
Genes encoding the core proteins of adenovirus type 2. J Biol Chem (1984) 1.03
An improved nuclear extract preparation method. Gene Anal Tech (1989) 1.03
Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments. J Virol (1998) 1.02
Glucose kinase of Streptomyces coelicolor A3(2): large-scale purification and biochemical analysis. Antonie Van Leeuwenhoek (2000) 1.01
Various methods for testing nasal responses in vivo: a critical review. Acta Otolaryngol (1995) 1.01
Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg (2002) 1.00
Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation. J Virol (2000) 1.00